Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LYI

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAWJ9-36-3

Summary for 7LYI
Entry DOI10.2210/pdb7lyi/pdb
Descriptor3C-like proteinase, GLYCEROL, SODIUM ION, ... (5 entities in total)
Functional Keywordsmpro, inhibitor, main protease, 3cl, sars, sars-cov-2, covid, covid-19, viral protein, viral protein-inhibitor complex, viral protein/inhibitor
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV)
Total number of polymer chains1
Total formula weight34639.48
Authors
Sacco, M.,Wang, J.,Chen, Y. (deposition date: 2021-03-07, release date: 2021-03-17, Last modification date: 2023-10-18)
Primary citationXia, Z.,Sacco, M.,Hu, Y.,Ma, C.,Meng, X.,Zhang, F.,Szeto, T.,Xiang, Y.,Chen, Y.,Wang, J.
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir.
Acs Pharmacol Transl Sci, 4:1408-1421, 2021
Cited by
PubMed: 34414360
DOI: 10.1021/acsptsci.1c00099
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon